GW Monogram

News - Cloned

  News

Recent Letters from the Director

Apr 2026 Letter from the Director

A Pathway to Coverage of GLP-1s in Medicare and Medicaid

A Pathway to Coverage of GLP-1s in Medicare and MedicaidA Pathway to Coverage of GLP-1s in Medicare and Medicaid

April 30, 2026

Last fall, the Trump administration announced an historic expansion of obesity treatment coverage for Medicare and Medicaid beneficiaries.

March 2026 Letter From Director

Weight Regain After Obesity Treatment

Weight Regain After Obesity Treatment

March 31, 2026

As options for the treatment of obesity have rapidly expanded, a major concern has been weight regain among treated patients with obesity.

February 2026 Letter from Director

Obesity Care Week 2026

Obesity Care Week 2026

February 27, 2026

Obesity Care Week (OCW) brings together advocates and organizations nationwide to raise awareness, educate, and advocate for people affected by obesity.

 

 

 

News Archive

Apr 2026 Letter from the Director

A Pathway to Coverage of GLP-1s in Medicare and Medicaid

Last fall, the Trump administration announced an historic expansion of obesity treatment coverage for Medicare and Medicaid beneficiaries.

March 2026 Letter From Director

Weight Regain After Obesity Treatment

As options for the treatment of obesity have rapidly expanded, a major concern has been weight regain among treated patients with obesity.

February 2026 Letter from Director

Obesity Care Week 2026

Obesity Care Week (OCW) brings together advocates and organizations nationwide to raise awareness, educate, and advocate for people affected by obesity.

January 2026 Letter from the Director

The New Dietary Guidelines for Americans, 2025-2030

Earlier this month, the US Department of Health and Human Services (HHS) and the US Department of Agriculture (USDA) released the 2025-2030 Dietary Guidelines for Americans (DGAs).

Jan 2026 Letter from the Director

Guest Letter: A Path Forward: What’s Possible for Obesity Care in 2026

Last month, the administration delivered another critical victory: a landmark Medicare and Medicaid price negotiation deal for the GLP-1 medications Wegovy and Zepbound.

Nov 2025 Letter from the Director

Obesity in the Workforce

Inclusive and supportive workplaces for people with obesity remain the exception rather than the norm.

OctoberLFD2025

The Changing Global Obesity Landscape

The global burden of obesity continues to rise.  Without effective and collective action, overweight and obesity will continue to increase globally.

Sep2025_LetterfromDirector

The Relationship between Obesity and the Immune System

This month STOP is exploring a topic that is relatively new to us, the relationship obesity has with immune health.

Aug 2025 Letter from the Director

The Role of Physical Activity in Obesity Treatment

Research has been clear that physical activity should be integrated into both the prevention and comprehensive treatments for obesity.

July 2025 Letter from the Director

Roadmap for Transforming Obesity Disease Management

Last month, the Center for Biomedical System Design (CBSD) program at Tufts Medical Center's Institute for Clinical Research and Health Policy Studies published a comprehensive roadmap for transforming obesity disease management in the United States.

Newsletter icon

Sign up for the monthly STOP Newsletter

Subscribe below to receive STOP's monthly email packed with insights from experts in obesity prevention and treatment, details on upcoming events, and exciting news from our member organizations!

* indicates required

Recent STOP Newsletters